SQZ Biotechnologies
(OTC) SQZB
SQZ Biotechnologies Financials at a Glance
Market Cap
$707,800
Revenue (TTM)
$12.12M
Net Income (TTM)
$71.64M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$0.02
Volume
1,000
Open
$0.02
Price
$0.02
Volume
1,000
Open
$0.02
Previous Close
$0.02
Daily Range
$0.02 - $0.02
52-Week Range
$0.02 - $0.05
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$0.02
Volume
1,000
Open
$0.02
Previous Close
$0.02
Daily Range
$0.02 - $0.02
52-Week Range
$0.02 - $0.05
SQZB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout SQZ Biotechnologies
Industry
Biotechnology
Sector
Health CareEmployees
53
CEO
Howard Bernstein, MD, PhD
Website
www.sqzbiotech.comHeadquarters
Watertown, MA 02472, US
SQZB Financials
Key Financial Metrics (TTM)
Gross Margin
47%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
0%
Return on Capital
-95%
Return on Assets
-74%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$707.80K
Shares Outstanding
29.49M
Volume
1.00K
Short Interest
0.00%
Avg. Volume
1.62K
Financials (TTM)
Gross Profit
$9.79M
Operating Income
$80.68M
EBITDA
$64.14M
Operating Cash Flow
$83.55M
Capital Expenditure
$522.00K
Free Cash Flow
$84.07M
Cash & ST Invst.
$63.71M
Total Debt
$34.37M
SQZ Biotechnologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$2.23M
-470.9%
Gross Margin
0.00%
N/A
Market Cap
$707.80K
N/A
Market Cap/Employee
$13.35K
N/A
Employees
53
N/A
Net Income
$23.64M
-4.4%
EBITDA
$13.35M
+34.0%
Quarterly Fundamentals
Net Cash
$11.28M
-151.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$19.07M
-63.2%
Short Term Debt
$2.40M
-77.4%
Return on Assets
-74.14%
N/A
Return on Invested Capital
-94.54%
N/A
Free Cash Flow
$14.53M
+33.9%
Operating Cash Flow
$14.53M
+33.6%